Keyphrases
Alcohol
5%
Cancer Risk
7%
Cirrhosis
80%
Cirrhotic Patients
7%
Clinical Trials Network
5%
Comorbid Conditions
7%
Decompensated Cirrhosis
7%
Developmental Signaling Pathways
7%
Disease Research
5%
Dysregulated
7%
Hepatic Decompensation
80%
Hepatic Dysfunction
8%
High Risk
5%
HMG-CoA Reductase Inhibitors
7%
In Cancer
5%
Institutional Support
5%
Interventional Trial
5%
Liver
10%
Liver Disease
14%
Liver Dysfunction
7%
Liver Function
14%
Liver Regeneration
14%
Liver Transplantation
5%
Longitudinal Cohort Study
7%
Metabolic Syndrome
5%
Modifiable Risk
7%
Multidisciplinary Team
5%
Non-alcoholic Fatty Liver Disease (NAFLD)
14%
Obesity
5%
Older Patients
7%
Organ Failure
5%
Personalized Approach
7%
Personalized Medicine
7%
Preclinical Research
7%
Regenerative Mechanism
7%
Statins
21%
Therapeutic Potential
7%
United States
5%
Medicine and Dentistry
Alcoholic Fatty Liver
8%
Anti-Inflammatory Drug
8%
Cancer Risk
8%
Clinical Research
7%
Cohort Analysis
8%
Decompensated Liver Cirrhosis
100%
Drive
8%
Liver Cirrhosis
100%
Liver Disease
17%
Liver Dysfunction
19%
Liver Function
17%
Liver Regeneration
17%
Liver Transplantation
7%
Malignant Neoplasm
14%
Metabolic Syndrome
8%
Nonalcoholic Fatty Liver
8%
Signal Transduction
7%
Statin
35%